Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

AGA linked to worse COVID-19 outcomes in men.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

The medication lopinavir-ritonavir may cause severe hair loss.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Six African American women experienced hair loss after switching to a new HIV medication.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Hair loss doesn't affect COVID-19 severity.

Tisseel shows promise for bone graft stabilization but needs more clinical trials to confirm its effectiveness.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.